| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,415,000 | 4,286,000 | 4,846,000 | 4,568,000 | | Cost of Revenue | 386,000 | 6,973,000 | 1,616,000 | 990,000 | | | Gross Profit | 3,029,000 | (2,687,000) | 3,230,000 | 3,578,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,012,000 | (4,181,000) | 1,667,000 | 2,301,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 345,000 | 353,000 | 348,000 | 346,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 672,000 | 1,141,000 | 1,215,000 | 931,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 23,000 | 25,000 | 23,000 | 19,000 | | Earnings Before Interest And Taxes | 695,000 | 1,166,000 | 1,238,000 | 950,000 | | Interest Expense | 141,000 | 127,000 | 130,000 | 128,000 | | Income Before Tax | 554,000 | 1,039,000 | 1,108,000 | 822,000 | | Income Tax Expense | 192,000 | 378,000 | 405,000 | 291,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 362,000 | 661,000 | 703,000 | 531,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 362,000 | 661,000 | 703,000 | 531,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $362,000 | $661,000 | $703,000 | $531,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
